
Tren A Injection 10 ML
$59.98 / unit
Available Options
| Pack Size | Price | Price / Unit | Quantity | Action |
|---|---|---|---|---|
| 10 Injection | $450.00 | $45.00/unit | ||
| 8 Injection | $360.00 | $45.00/unit | ||
| 6 Injection | $273.00 | $45.50/unit | ||
| 4 Injection | $191.00 | $47.75/unit | ||
| 2 Injection | $108.00 | $54.00/unit | ||
| 1 Injection | $60.00 | $60.00/unit |
Product Description
What is this medicine?
TREN A INJECTION contains Trenbolone Acetate, a potent synthetic anabolic-androgenic steroid (AAS).
Current products sold under the TREN A/TREN-A name include different presentations.
One current Indian seller lists:
Brand Name: TREN A
Active Ingredient: Trenbolone Acetate
Listed Strength: 100 mg
Vial Size: 10 mL
Manufacturer: John Albert Pharma
Another current product, from Zovexa Pharma, is labeled:
Brand Name: TREN-A
Active Ingredient: Trenbolone Acetate
Strength: 150 mg/mL
Vial Size: 10 mL
Route: For I.M. use only
Therefore, do not assume that every TREN A 10 mL vial is 100 mg/mL. Verify the exact concentration printed on your physical product before calculating total vial content or publishing the strength.
Trenbolone acetate is an ester of trenbolone, a synthetic androgen with strong anabolic and androgenic activity. FDA's substance database recognizes trenbolone acetate as a drug substance, but specifically states that inclusion in the database does not imply regulatory review or approval.
Trenbolone can affect:
androgen-responsive tissues
protein metabolism
muscle tissue
natural reproductive-hormone production
sperm production and fertility
red blood cell production
blood pressure
cholesterol
cardiovascular function
mood and behavior
Human regulatory status
I could not verify an FDA-approved trenbolone acetate injection for human therapeutic use.
Current FDA-approved trenbolone acetate products are found in the veterinary cattle-implant setting, where trenbolone acetate is used alone or with other hormones to improve growth rate and feed efficiency in cattle.
For example, FDA documentation for Finaplix identifies:
Active Ingredient: Trenbolone Acetate
Dosage Form: Pellet
Route: Ear implant
Species: Cattle
—not human intramuscular therapy.
Therefore, TREN A should not be described as an FDA-approved human treatment for:
low testosterone
testosterone replacement therapy
muscle wasting
bodybuilding
cutting
athletic-performance enhancement
cosmetic muscle gain
What should I tell my health care provider before I take this medicine?
Tell your healthcare provider about your complete medical history, particularly if you have:
previous heart attack
previous stroke
high blood pressure
abnormal cholesterol or triglycerides
history of blood clots
high haemoglobin or haematocrit
polycythaemia
kidney disease
liver disease
prostate enlargement
prostate cancer
male breast cancer
sleep apnoea
epilepsy
fertility problems
plans to father a child
erectile or sexual-function problems
anxiety
depression
severe irritability or aggression
another psychiatric condition
significant swelling or fluid retention
Also tell your healthcare provider if you use:
warfarin or another anticoagulant
insulin
other diabetes medicines
corticosteroids
blood-pressure medicines
cholesterol medicines
psychiatric medicines
other performance-enhancing substances
Fertility warning
Anabolic-androgenic steroids can suppress the hypothalamic-pituitary-gonadal axis, reducing the body's production of reproductive hormones.
Possible effects in men include:
reduced natural testosterone production
reduced sperm production
oligospermia
azoospermia
testicular shrinkage
decreased fertility
infertility
erectile dysfunction
changes in sexual desire
A systematic review of AAS exposure found associations with testicular atrophy, azoospermia and anabolic-steroid-induced hypogonadism.
Recovery after stopping anabolic steroids varies significantly between individuals and can take considerable time.
Pregnancy warning
Trenbolone is a potent androgenic substance.
Androgen exposure during pregnancy may interfere with normal fetal sexual development. Pregnant women should avoid exposure to anabolic-androgenic steroids unless specifically directed in an authorized medical context.
How should I use this medicine?
There is no verified regulator-approved standard human dosing regimen for TREN A Trenbolone Acetate Injection.
This is particularly important because current products using the TREN A/TREN-A name are sold in different concentrations.
For example:
one current TREN A listing states 100 mg, 10 mL
Zovexa Pharma TREN-A is explicitly labeled 150 mg/mL, 10 mL
If a physical vial is labeled 100 mg/mL, a 10 mL vial would contain a nominal 1,000 mg in total.
If a physical vial is labeled 150 mg/mL, a 10 mL vial would contain a nominal 1,500 mg in total.
The total amount in a 10 mL vial is not a recommended dose.
No authoritative human prescribing information could be verified establishing for this product:
a recommended human starting dose
a maintenance dose
a standard injection frequency
a maximum safe human dose
an approved treatment duration
a bodybuilding cycle
a cutting cycle
FDA documentation instead describes trenbolone acetate in cattle implant products. Some FDA animal-drug labeling explicitly states “FOR USE IN ANIMALS ONLY – NOT FOR HUMAN USE.”
For this reason:
do not determine a dose from bodybuilding forums
do not assume 1 mL is an appropriate dose
never assume the whole 10 mL vial is a dose
do not increase the amount for faster muscle gain
do not shorten injection intervals
do not use veterinary dosing information in humans
do not combine trenbolone with other anabolic steroids based on a bodybuilding “stack”
do not substitute trenbolone for medically prescribed testosterone replacement therapy
If a person is already using or has recently used trenbolone, a healthcare professional may consider monitoring:
blood pressure
complete blood count
haemoglobin
haematocrit
cholesterol
LDL cholesterol
HDL cholesterol
triglycerides
kidney function
liver function
blood glucose
testosterone
LH
FSH
fertility parameters where appropriate
cardiovascular symptoms
psychiatric symptoms
There is no medically established universal “Tren A cycle” that should be presented as a therapeutic regimen.
What if I miss a dose?
Because TREN A does not have a verified regulator-approved human therapeutic dosing schedule, there is no standardized human missed-dose recommendation.
Do not:
inject an extra amount
double the next amount
shorten the injection interval
use additional medicine to compensate
follow a steroid-cycle schedule to replace a missed injection
If the exact product has been supplied under legitimate medical supervision in a jurisdiction where it has an authorized indication, follow the instructions of the prescribing healthcare professional.
What may interact with this medicine?
Controlled human drug-interaction studies specifically involving trenbolone acetate injections are very limited, so a complete evidence-based interaction list cannot be established.
Nevertheless, tell your healthcare provider if you take:
warfarin
other anticoagulants
insulin
oral diabetes medicines
corticosteroids
ACTH
testosterone
nandrolone
drostanolone
stanozolol
oxandrolone
oxymetholone
methandienone
other anabolic steroids
blood-pressure medicines
medicines affecting cholesterol
medicines affecting fluid balance
Other anabolic-androgenic steroids
Combining trenbolone with other anabolic steroids can substantially increase total androgen exposure.
This may compound risks involving:
blood pressure
cholesterol
cardiovascular function
red blood cell count
reproductive-hormone suppression
fertility
sexual function
mood and behavior
AAS misuse is associated with multisystem toxicity, particularly involving the cardiovascular and reproductive systems.
Anticoagulants
Because androgenic-anabolic steroids as a class may affect coagulation and cardiovascular risk factors, anyone using anticoagulants such as warfarin should disclose anabolic-steroid exposure to their healthcare professional.
Diabetes medicines
Anabolic-androgenic steroids may affect metabolic and glucose regulation.
People receiving:
insulin
sulfonylureas
metformin
other glucose-lowering treatment
should disclose anabolic-steroid exposure so blood glucose can be monitored appropriately.
Give your healthcare professional a complete list of all:
prescription medicines
non-prescription medicines
injections
hormones
vitamins
supplements
herbal medicines
performance-enhancing substances
What should I watch for while using this medicine?
Seek prompt medical attention if you develop:
chest pain
sudden shortness of breath
fainting
rapid or irregular heartbeat
severe or persistent high blood pressure
severe unexplained headache
sudden weakness or numbness
pain or swelling in one leg
major ankle or leg swelling
major reduction in urine output
yellowing of the skin or eyes
dark urine
severe anxiety
severe depression
extreme aggression
suicidal thoughts
prolonged or painful erection
severe allergic reaction
Cardiovascular health
Anabolic-androgenic steroid misuse has been linked with significant cardiovascular problems.
Potential complications include:
hypertension
unfavorable cholesterol changes
increased haematocrit
thrombosis
arrhythmias
cardiomyopathy
impaired heart function
myocardial infarction
stroke
Recent and earlier medical reviews consistently identify cardiovascular disease as a major concern with chronic supraphysiologic anabolic-steroid exposure.
Cholesterol
Anabolic-androgenic steroids may produce unfavorable changes such as:
reduced HDL cholesterol
increased LDL cholesterol
altered triglycerides
These changes can contribute to long-term cardiovascular risk.
Red blood cell count
AAS exposure can increase:
red blood cell count
haemoglobin
haematocrit
Excessive haematocrit may increase blood viscosity and contribute to:
thrombosis
stroke
other cardiovascular complications
A clinical review specifically identifies increased haematocrit and coagulation among important adverse effects of high-dose AAS exposure.
Hormonal suppression
Trenbolone and other anabolic steroids can suppress normal reproductive-hormone production.
Possible consequences include:
low endogenous testosterone
reduced sperm production
testicular shrinkage
infertility
changes in sexual desire
erectile dysfunction
AAS-associated reproductive dysfunction may be temporary in some individuals but may persist for prolonged periods in others.
Kidney health
Long-term or high-dose AAS misuse has been associated with kidney injury in addition to cardiovascular and endocrine complications. MedlinePlus includes kidney damage among recognized harms of anabolic-steroid misuse.
Seek medical attention if you notice:
markedly reduced urine output
blood in the urine
severe swelling
unexplained shortness of breath
Psychiatric effects
Anabolic-androgenic steroid misuse may be associated with:
irritability
aggression
anxiety
insomnia
mood changes
depressive symptoms
dependence
withdrawal symptoms
MedlinePlus specifically identifies irritability and aggressive behavior among possible consequences of anabolic-steroid misuse.
Women
Potent androgen exposure may cause virilizing effects such as:
acne
increased facial or body hair
scalp hair loss
menstrual irregularities
deepening of the voice
clitoral enlargement
Some androgenic changes, especially voice deepening, may not fully reverse.
Children and adolescents
Anabolic steroid exposure can interfere with normal growth and endocrine development.
Possible consequences include:
premature skeletal maturation
growth-plate closure
reduced final adult height
abnormal sexual development
MedlinePlus identifies stunted growth in teenagers as a recognized risk of anabolic-steroid misuse.
Athletic competition
Trenbolone is specifically listed under S1 Anabolic Agents in the 2026 WADA Prohibited List and is prohibited at all times, both in and out of competition.
Misuse warning
TREN A should not be considered medically safe simply because it is supplied in a pharmaceutical-style vial.
Non-medical use for:
bodybuilding
bulking
cutting
muscle definition
strength enhancement
athletic performance
cosmetic physique enhancement
can expose users to serious cardiovascular, endocrine, reproductive, renal and psychiatric risks.
What side effects may I notice from this medicine?
Because trenbolone acetate does not have a verified modern approved human prescribing label, reliable clinical-trial frequencies for human adverse reactions are not available.
Side effects that should receive prompt medical attention:
chest pain
severe shortness of breath
fainting
severe or persistent high blood pressure
rapid or irregular heartbeat
symptoms of a possible blood clot
severe neurological symptoms
significant swelling
serious kidney symptoms
yellowing of the skin or eyes
severe mood or behavioral changes
severe depression
suicidal thoughts
prolonged or painful erection
severe allergic reaction
Other possible effects associated with anabolic-androgenic steroid exposure:
acne
oily skin
increased sweating
headache
insomnia
irritability
anxiety
mood changes
changes in sexual desire
elevated blood pressure
abnormal cholesterol
increased haemoglobin or haematocrit
reduced sperm production
testicular shrinkage
reduced fertility
erectile or sexual-function changes
injection-site discomfort
MedlinePlus identifies acne, high blood pressure, cholesterol changes, heart problems, kidney damage, mood changes and male infertility among recognized harms associated with anabolic-steroid misuse.
In women, possible androgenic effects include:
facial or body-hair growth
acne
menstrual changes
male-pattern scalp hair loss
deepening of the voice
clitoral enlargement
This list may not describe all possible adverse effects.
Where should I keep my medicine?
Keep TREN A 10 ML INJECTION out of the reach of children.
Because products sold as TREN A come from different manufacturers and concentrations, follow the exact storage instructions printed on the original vial and carton.
Do not transfer storage instructions from one TREN A manufacturer to another.
In general, keep the vial:
in its original packaging
protected from excessive heat
protected from direct sunlight
protected from contamination
protected from physical damage
away from unauthorized access
Do not use the product if:
the vial is cracked
the seal is damaged or appears tampered with
the solution contains unexpected particles
the solution has changed appearance
contamination is suspected
the expiration date has passed
authenticity cannot be verified
Because a 10 mL vial may be intended as a multidose presentation, strict sterile handling is particularly important.
Never share needles or syringes.




